Menu Search
Equities

Voxel SA

VOX:WSE

Voxel SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (PLN)93.00
  • Today's Change0.80 / 0.87%
  • Shares traded27.04k
  • 1 Year change+111.85%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Voxel SA is a Poland-based company active in the healthcare sector. It provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.

  • Revenue in PLN (TTM)424.18m
  • Net income in PLN80.89m
  • Incorporated2005
  • Employees467.00
  • Location
    Voxel SAul. Wielicka 265KRAKOW 30-663PolandPOL
  • Phone+48 326060500
  • Fax+48 326060519
  • Websitehttps://voxel.pl/
More ▼

Institutional shareholders

11.55%Per cent of shares held by top holders
HolderShares% Held
TFI PZU SAas of 30 Jun 2023437.74k4.17%
Norges Bank Investment Managementas of 31 Dec 2023256.48k2.44%
Generali PTE SAas of 29 Dec 2023247.31k2.36%
Pekao TFI SAas of 30 Jun 2023101.81k0.97%
Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 31 Dec 202286.33k0.82%
Rockbridge TFIas of 30 Jun 202363.04k0.60%
IPOPEMA TFI SAas of 31 Dec 202320.00k0.19%
SSgA Funds Management, Inc.as of 04 Apr 202498.000.00%
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.